Inflachek Tablet is a combination pharmaceutical formulation containing Bromelain (90 mg), Trypsin (48 mg), and Rutoside (100 mg), designed to provide anti-inflammatory, proteolytic, and vasoprotective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins, thereby reducing inflammation and edema associated with trauma, surgery, or chronic inflammatory conditions. Trypsin, another proteolytic enzyme, complements Bromelain by enhancing the degradation of inflammatory mediators and promoting tissue repair. Rutoside, a bioflavonoid, exhibits antioxidant properties and strengthens capillary walls, reducing capillary permeability and fragility, which aids in minimizing bruising and hemorrhagic conditions. The synergistic action of these active ingredients makes Inflachek Tablet effective in managing acute and chronic inflammatory disorders, including musculoskeletal injuries, postoperative swelling, and vascular insufficiencies. It is indicated for use as an adjunct therapy in conditions requiring reduction of inflammation, pain, and edema. The medication should be administered under medical supervision, considering contraindications such as hypersensitivity to any component, bleeding disorders, or concurrent anticoagulant therapy. Common side effects are generally mild but may include gastrointestinal discomfort or allergic reactions. Inflachek Tablet offers a targeted approach to inflammation management by combining enzymatic and vascular protective mechanisms.